Number of qualified individuals: CDEC talked about the uncertainty in the number of people with moderately serious to severe hemophilia B in Canada qualified for etranacogene dezaparvovec. Medical authorities consulted by CADTH indicated that some patients who're labeled as acquiring gentle or reasonable disorder can have a critical bleeding phenotype, https://hallen801zyw1.wiki-racconti.com/user